← Back to Search

Behavioral Intervention

Health Messaging for Tobacco Use Prevention in LGBT Young Adults

N/A

Waitlist Available

Led By Joanne G Patterson, PhD

Research Sponsored by Ohio State University Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately post-exposure to intervention

Awards & highlights

Study Summary

This trial evaluates how to better communicate the risks of polytobacco use to LGBT youth to reduce nicotine dependence and tobacco use in adulthood.

Who is the study for?

This trial is for LGBT young adults in the U.S. who speak English fluently, have access to a computer with a camera, identify as non-heterosexual or non-binary, and currently use e-cigarettes, regular cigarettes, or both. It's not for those with glaucoma or cataracts.Check my eligibility

What is being tested?

The study is testing how anti-tobacco messages designed specifically for the LGBT community affect their views on using multiple tobacco products. The goal is to see if these targeted health communications can reduce polytobacco use among at-risk individuals.See study design

What are the potential side effects?

Since this trial involves health communication interventions rather than medical treatments, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline in behavioral intentions at 1-week follow-up after intervention exposure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline in behavioral intentions at 1-week follow-up after intervention exposure

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline in behavioral intentions at 1-week follow-up after intervention exposure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in behavioral intentions

Change in harm perceptions

Perceived message effectiveness - effects perceptions

+3 more

Secondary outcome measures

Ad relevance

Attitudes

Liking

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Non-targeted messagesExperimental Treatment1 Intervention

Participants will view 8 nicotine and tobacco health messages with universal messages and imagery

Group II: Culturally targeted messagesExperimental Treatment1 Intervention

Participants will view 8 nicotine and tobacco health messages with LGBT culturally targeted messages and imagery

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Health communications

2023

N/A

~3110

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH

2,701 Previous Clinical Trials

7,506,598 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,672 Previous Clinical Trials

40,926,189 Total Patients Enrolled

Ohio State University Comprehensive Cancer CenterLead Sponsor

320 Previous Clinical Trials

289,843 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial open to participants aged 20 and above?

"As stipulated in the inclusion criteria for this study, only participants between 18 and 35 years old are eligible."

Answered by AI

Are there opportunities for volunteers to participate in this experiment?

"Affirmative. According to the records on clinicaltrials.gov, this medical investigation is currently seeking participants; it was first announced on June 19th 2023 and last revised July 25th of that same year. 200 patients are required from one location in order for trial success."

Answered by AI

How many participants are being monitored during this research project?

"Affirmative. Clinicaltrials.gov hosts data that reveals this clinical trial is actively recruiting participants, with an original posting date of June 19th 2023 and a recent edit on July 25th 2023. This research seeks 200 volunteers from 1 specific medical centre."

Answered by AI

What is the principal aim of this clinical trial?

"The primary efficacy metric of this research is the amount of time it takes for participants to fixate on visual stimuli. Secondary objectives involve gauging participant's attitudes towards the ads with a 5-item 7-point Likert Scale and assessing their overall satisfaction, as measured by one item in a 5-point Likert scale. Additionally, two items are evaluated through another 7-Point Likert scale which will measure how subjects perceive changes in their sentiment regarding combustible cigarettes and vaping nicotine."

Answered by AI

Am I eligible to be included in this experiment?

"Eligible candidates for this clinical trial must have a diagnosis of tobacco-induced cancer and be between 18 to 35 years old. This research is expecting around 200 volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Nicotine and Tobacco Message Framing Among LGBT Young Adults

Joanne Patterson 2023. "Nicotine and Tobacco Message Framing Among LGBT Young Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05972941.